Elevated Capital Advisors, LLC Zoetis Inc. Transaction History

Elevated Capital Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	SELL	$131.14 - $157.47 $1.02 Million - $1.22 Million	-7,758 Closed	0 $0
Q3 2022 Oct 06, 2022	SELL	$148.29 - $182.55 $31,585 - $38,883	-213 Reduced 2.67%	7,758 $1.15 Million
Q1 2022 Apr 20, 2022	SELL	$181.39 - $234.03 $9,250 - $11,935	-51 Reduced 0.64%	7,971 $1.5 Million
Q3 2021 Oct 07, 2021	BUY	$189.29 - $209.69 $176,796 - $195,850	934 Added 13.18%	8,022 $1.56 Million
Q1 2021 Apr 21, 2021	BUY	$144.0 - $169.39 $81,072 - $95,366	563 Added 8.63%	7,088 $1.2 Million
Q4 2020 Feb 25, 2021	BUY	$157.07 - $174.35 $72,566 - $80,549	462 Added 7.62%	6,525 $1.08 Million
Q3 2020 Nov 27, 2020	SELL	$137.1 - $165.37 $140,801 - $169,834	-1,027 Reduced 14.49%	6,063 $986,000
Q2 2020 Sep 11, 2020	BUY	$111.92 - $142.53 $793,512 - $1.01 Million	7,090 New	7,090 $1.17 Million
Q4 2019 Feb 06, 2020	SELL	$116.25 - $133.25 $487,087 - $558,317	-4,190 Closed	0 $0
Q1 2019 Apr 16, 2020	BUY	$81.56 - $100.67 $341,736 - $421,807	4,190 New	4,190 $519,000

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Elevated Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Elevated Capital Advisors, LLC with notifications on news.